Majority of the clinically diagnosed FH patients (~80%) have a mono-allelic loss-of-function (LoF) variant in LDLR gene, while the rest are LoF variants in the receptor-binding domain of the APOB gene or a gain-of-function (GoF) variant in the PCSK9 gene. Here, LDLR is linked to familial hyperaldosteronism.